Renin-angiotensin blockade in diabetic retinopathy

Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review

(2011) A. K. Sjølie et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Candesartan Attenuates Diabetic Retinal Vascular Pathology by Restoring Glyoxalase-I Function

(2010) A. G. Miller et al.   DIABETES

The renin–angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature

(2010) Erica L. Fletcher et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Enalapril Alters Expression of Key Growth Factors in Experimental Diabetic Retinopathy

(2009) Hyun Woong Kim et al.   CURRENT EYE RESEARCH

(Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy?

(2009) J. L. Wilkinson-Berka et al.   DIABETES

The evolving story of the RAAS in hypertension, diabetes and CV disease - moving from macrovascular to microvascular targets

(2009) Ulrike Muscha Steckelings et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes

(2009) Michael Mauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology

(2008) Jennifer L. Wilkinson-Berka et al.   CIRCULATION RESEARCH

Vascular endothelial growth factor and diabetic nephropathy

(2008) Sheldon Chen et al.   Current Diabetes Reports

Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic Retina

(2008) T. Kurihara et al.   DIABETES

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

(2008) Nish Chaturvedi et al.   LANCET

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

(2008) Anne Katrin Sjølie et al.   LANCET